|
GB0703492D0
|
|
The treatment of hyperhidrosis
|
|
GB0703491D0
|
|
The treatment of hyperhidrosis
|
|
GB0625844D0
|
|
The treatment of macular degeneration
|
|
GB0625602D0
|
|
Treatment of sialorrhoea
|
|
GB0625603D0
|
|
The treatment of hyperhidrosis
|
|
GB0617225D0
|
|
Methods of screening for teratogenic compounds or effects
|
|
GB0611239D0
|
|
A treatment to reduce sebum excretion
|
|
GB0611240D0
|
|
The treatment of increased sebum production
|
|
GB0611241D0
|
|
The treatment of increased sebum production
|
|
GB0609880D0
|
|
Model of neurodegenerative disorder for use in screening methods
|
|
GB0603076D0
|
|
The treatment of hyperhidrosis
|
|
GB0603074D0
|
|
The treatment of hyperhidrosis
|
|
GB0603075D0
|
|
The treatment of hyperhidrosis
|
|
GB0602855D0
|
|
The Treatment Of Sialorrhoea
|
|
GB0602857D0
|
|
The treatment of sialorrhoea
|
|
GB0602858D0
|
|
The treatment of sialorrhoea
|
|
GB0601091D0
|
|
The Treatment Of Ocular Conditions
|
|
GB0601092D0
|
|
The Prevention Of Systemic Side-Effects Of Glucocorticoids
|
|
WO2005067708A2
|
|
Zebrafish model for autoimmune diseases
|
|
GB0417290D0
|
|
Therapeutic use of noscapine and analogue therof
|
